5.2 Peritoneal Dialysis & Peritoneal Glucose Absorption Assessment

Peritoneal Dialysis & Peritoneal Glucose Absorption Assessment

Peritoneal Dialysis (PD) utilizes the patient's living peritoneal membrane as a semipermeable bidirectional transport barrier. Solute clearance occurs between mesenteric capillary blood and hypertonic dialysate instilled into the peritoneal cavity. For the renal nutrition specialist, PD presents unique metabolic challenges: continuous transperitoneal absorption of dextrose creates a substantial caloric burden, while persistent peritoneal effluent protein and amino acid losses dramatically escalate dietary protein requirements.

---

Peritoneal Membrane Physiology: The Three-Pore Model

The universally accepted biophysical framework describing peritoneal transport is the Three-Pore Model formulated by Bengt Rippe. Transport kinetics across the capillary endothelium are governed by three anatomically and functionally distinct pore sizes:

┌────────────────────────────────────────────────────────────────────────┐
│                     Peritoneal Three-Pore Framework                    │
├────────────────────────────────────────────────────────────────────────┤
│  1. Large Pores (Radius: 20 – 40 nm)                                   │
│  • Represent < 0.01% of total pore area.                               │
│  • Located at inter-endothelial gaps / post-capillary venules.         │
│  • Mediate macromolecular transport: serum albumin, immunoglobulins.   │
│  • Responsible for baseline effluent loss: 5–15 g protein/day.         │
│                                                                        │
│  2. Small Pores (Radius: 4.0 – 4.5 nm)                                 │
│  • Represent 90% – 95% of total pore surface area.                     │
│  • Located between endothelial cell clefts.                            │
│  • Mediate small solute clearance: urea, creatinine, Na+, K+, glucose. │
│  • Primary pathway for small-molecule diffusion and convection.        │
│                                                                        │
│  3. Ultrasmall Pores / Aquaporin-1 (Radius: 0.25 – 0.4 nm)             │
│  • Represent 1% – 2% of total hydraulic conductance.                   │
│  • Transcellular water channels (Aquaporin-1) exclusively for water.   │
│  • Mediate 40% – 50% of ultrafiltration during hypertonic dwells.      │
│  • Generate "Sodium Sieving" (transcellular water dilutes dialysate Na)│
└────────────────────────────────────────────────────────────────────────┘

The Sodium Sieving Phenomenon

During the initial 60 to 90 minutes of a hypertonic dextrose dwell, crystalloid osmosis drives transcellular water flux across ultrasmall aquaporin-1 channels into the peritoneal cavity. Because aquaporins reject solutes, pure water enters the dialysate without accompanying sodium. This process dilutes the dialysate sodium concentration below the baseline bath level (typically a fall of roughly 5–10 mEq/L in the first hour of a hypertonic 4.25% dwell), a diagnostic hallmark known as sodium sieving. Failure of dialysate sodium to dip indicates aquaporin dysfunction or loss of membrane ultrafiltration capacity.

Peritoneal Equilibration Test (PET) & Transporter Categorization

The standard 4-hour Peritoneal Equilibration Test (PET) using a 2.5% dextrose dwell categorizes patients into four transport phenotypes based on the dialysate-to-plasma creatinine ratio ($D/P_{cr}$) and dialysate glucose retention ($D/D_0$):

• High (Fast) Transporters ($D/P_{cr} > 0.81$): Rapid solute equilibrium. Glucose absorbs very rapidly, dissipating the osmotic gradient quickly. Patients achieve excellent small-solute clearance but suffer poor ultrafiltration on long dwells, absorbing massive dextrose calorie loads and losing high amounts of protein.
• High-Average Transporters ($D/P_{cr} = 0.65\text{--}0.81$): Balanced solute clearance and ultrafiltration; well-suited for automated peritoneal dialysis (APD) or standard continuous ambulatory peritoneal dialysis (CAPD).
• Low-Average Transporters ($D/P_{cr} = 0.50\text{--}0.64$): Slower equilibrium; excellent sustained ultrafiltration during long dwells; ideal for standard CAPD.
• Low (Slow) Transporters ($D/P_{cr} < 0.50$): Sluggish solute clearance but robust sustained ultrafiltration; requires large exchange volumes or long dwells to achieve adequacy.

---

Peritoneal Dialysis Modalities

1. Continuous Ambulatory Peritoneal Dialysis (CAPD): Manual, gravity-assisted exchanges performed 4 to 5 times daily. Each exchange dwells for 4 to 6 hours during daytime and 8 to 10 hours overnight. Solute removal is continuous and steady.
2. Automated Peritoneal Dialysis (APD / CCPD): An automated mechanical cycler performs 3 to 6 rapid exchanges overnight over 8 to 10 hours while the patient sleeps. The cycler may leave the abdomen "dry" during the day or instill a long daytime manual or automated dwell ("wet day") to optimize solute clearance.

---

Transperitoneal Dextrose & Caloric Absorption Calculations

Commercial peritoneal dialysate utilizes dextrose monohydrate as the crystalloid osmotic agent to generate transmembrane hydrostatic and osmotic gradients.

Dextrose Solution Concentrations

Dialysate formulations are labeled by dextrose monohydrate concentration:

• 1.5% Solution: 1.5 g/dL = 15 g/L (anhydrous dextrose equivalent = 1.36% or 13.6 g/L).
• 2.5% Solution: 2.5 g/dL = 25 g/L (anhydrous dextrose equivalent = 2.27% or 22.7 g/L).
• 4.25% Solution: 4.25 g/dL = 42.5 g/L (anhydrous dextrose equivalent = 3.86% or 38.6 g/L).

Energy Value of Dextrose Monohydrate

Dextrose monohydrate yields 3.4 kcal per gram, distinguishing it from anhydrous glucose or dietary carbohydrates (4.0 kcal/g).

Dextrose Absorption Fraction ($F_{abs}$)

The proportion of instilled dextrose absorbed across the peritoneal capillary bed depends on dwell duration and membrane transport category:

• CAPD (Long Dwells, 4–8 hours): Approximately 60% to 70% (mean ~65%) of instilled dextrose is absorbed into systemic circulation.
• APD (Short Nighttime Dwells, 1–2 hours): Approximately 40% to 50% (mean ~45%) of instilled dextrose is absorbed due to rapid cycling.

Mathematical Formulation for Caloric Absorption

To quantify total daily dialysate caloric contribution, the dietitian applies the following formula:

$\text{Daily Absorbed Dextrose (g)} = \sum \left[ \text{Instilled Volume (L)} \times \text{Dextrose Conc (g/L)} \times F_{abs} \right]$

$\text{Total Dialysate Calories (kcal/day)} = \text{Daily Absorbed Dextrose (g)} \times 3.4\text{ kcal/g}$

Worked Clinical Example

A CAPD patient uses three 2.0-liter bags of 2.5% dextrose and one 2.0-liter bag of 4.25% dextrose daily. Assuming an average absorption fraction of 65% ($0.65$):

1. Grams Dextrose Instilled:
   • Three 2.0 L bags of 2.5%: $3 \times 2.0\text{ L} \times 25\text{ g/L} = 150\text{ g}$
   • One 2.0 L bag of 4.25%: $1 \times 2.0\text{ L} \times 42.5\text{ g/L} = 85\text{ g}$
   • Total instilled dextrose: $150\text{ g} + 85\text{ g} = 235\text{ g/day}$
2. Grams Dextrose Absorbed:
   • $235\text{ g} \times 0.65 = 152.75\text{ g absorbed/day}$
3. Caloric Contribution:
   • $152.75\text{ g} \times 3.4\text{ kcal/g} = 519.35\text{ kcal/day}$ (~520 kcal/day).

Metabolic Consequences of Glucose Absorption

Absorbing 300 to 800+ kcal daily of transperitoneal dextrose induces profound metabolic alterations:

• Appetite Suppression & Oral Anorexia: Transperitoneal glucose infusions suppress hunger signals, inducing early satiety. Patients consume insufficient dietary protein, leading to sarcopenia masked by fluid and fat gain.
• Atherogenic Dyslipidemia: Continuous glucose influx promotes hepatic de novo lipogenesis, provoking marked hypertriglyceridemia (often $> 400\text{--}800$ mg/dL) and elevated small, dense LDL particles.
• Weight Gain & Central Adiposity: Patients gain substantial adipose tissue, particularly visceral fat, accelerating metabolic syndrome.
• Worsening Glycemic Control: In diabetic individuals, continuous glucose absorption causes refractory hyperglycemia, frequently necessitating intraperitoneal (IP) insulin regimens.

---

Alternative Osmotic Agents: Icodextrin

Icodextrin is a 7.5% solution containing high-molecular-weight glucose polymers derived from corn starch. Unlike dextrose, which generates crystalloid osmosis, icodextrin functions via colloid osmosis, exerting sustained oncotic pressure across small endothelial pores over long dwell intervals (8 to 16 hours). It is exceptionally effective for the long daytime dwell in APD or overnight dwell in CAPD.

Caloric and Fluid Advantages

Because icodextrin is a large polymer, it is absorbed very slowly via the peritoneal lymphatics rather than capillaries. It does not contribute significant dextrose calories, blunts hyperinsulinemia, and preserves ultrafiltration in fast transporters.

Fatal Laboratory Interference: GDH-PQQ Glucometer Alert

Critical Safety Warning: Absorbed icodextrin is metabolized by circulating alpha-amylase into maltose, maltotriose, and maltotetraose. Circulating maltose cross-reacts with point-of-care capillary glucometers using glucose dehydrogenase pyrroloquinoline quinone (GDH-PQQ) or glucose-dye-oxidoreductase testing methods.

The glucometer misinterprets maltose as glucose, displaying falsely elevated blood glucose readings (often > 300–400 mg/dL). If patients or unaware clinicians administer corrective rapid-acting insulin, catastrophic, fatal neuroglycopenic hypoglycemia ensues. Patients prescribed icodextrin must exclusively utilize glucose-specific monitors incorporating glucose oxidase (GOD) or glucose dehydrogenase flavin-adenine dinucleotide (GDH-FAD).

---

Peritoneal Protein & Amino Acid Effluent Losses

Unlike hemodialysis where the intact dialyzer membrane prevents intact protein leakage, the large pores of the peritoneal capillary bed allow continuous passive transudation of macromolecules into the dialysate.

Peritonitis-Induced Protein Hypercatabolism

Acute bacterial peritonitis induces severe peritoneal vasodilation and inflammatory widening of endothelial large pores. Daily effluent protein losses surge from 5–15 g/day to 20 to 30+ g/day, persisting for several weeks following clinical resolution of infection. This acute macromolecular drain rapidly precipitates refractory hypoalbuminemia ($< 3.0$ g/dL), peripheral edema, and muscle wasting. The renal dietitian must aggressively increase protein intake to 1.5–2.0 g/kg/day, utilizing high-biological-value modular protein supplements to prevent fatal protein-energy wasting.